Cipla Inc. Overview
Company Headquarters: Mumbai, India
Founded: 1935
Workforce: ~25,000+
Company Working: Cipla Inc. (Cipla) is a global pharmaceutical company with a portfolio of over 1000 products across a wide range of therapeutic categories with one quality standard globally. Its products are available in more than 50 dosage forms. The company has 46 manufacturing facilities for the production of APIs and formulations across various therapeutic categories. Its products are in compliance with the Medicines and Healthcare Products Regulatory Agency (MHRA), US FDA, Danish Medicines Agency, Health Canada, Federal Ministry of Health, the National Health Surveillance Agency (ANVISA) Brazil, Medicines Control Council (MCC) South Africa, the Colombia National Food and Drug Surveillance Institute (INVIMA), and Australian Government Department of Health. Cipla has presence in India, the US, Germany, Norway, Spain, the UK, Sri Lanka, South Africa, Australia, and Brazil, among other countries.
Strategy
Cipla is focused on investments for the development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments, and the strengthening of platform technologies.
